Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.50
Delayed Data
As of Feb 27
 +0.41 / +37.61%
Today’s Change
0.51
Today|||52-Week Range
4.14
+114.32%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 9.50, with a high estimate of 10.00 and a low estimate of 9.00. The median estimate represents a +533.33% increase from the last price of 1.50.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Cyclacel Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.26
Sales
$175.0K
Reporting Date
Mar 25

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -18.18%
 
 
 
 
 
 
Growthannually 25.78%
 
 
 
 
 
 

Sales

Growthquarterly -76.19%
 
 
 
 
 
 
Growthannually 53.92%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account